Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma
(Q45183209)
scientific article published in December 2004
scientific article published in December 2004
Language:
Current Data About
Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma